{"id":"NCT00688740","sponsor":"Sanofi","briefTitle":"Docetaxel in Node Positive Adjuvant Breast Cancer","officialTitle":"A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-fluorouracil in Combination With Doxorubicin and Cyclophosphamide (FAC) as Adjuvant Treatment of Operable Breast Cancer Patients With Positive Axillary Lymph Nodes.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1997-06","primaryCompletion":"2010-01","completion":"2010-01","firstPosted":"2008-06-03","resultsPosted":"2011-02-14","lastUpdate":"2011-02-16"},"enrollment":1491,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Docetaxel","otherNames":["TaxotereÂ®"]},{"type":"DRUG","name":"5-fluorouracil","otherNames":["5-FU"]},{"type":"DRUG","name":"Doxorubicin","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]}],"arms":[{"label":"TAC (Docetaxel)","type":"EXPERIMENTAL"},{"label":"FAC (5-fluorouracil)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study was to compare disease-free survival after treatment with docetaxel in combination with doxorubicin and cyclophosphamide to 5-fluorouracil in combination with doxorubicin and cyclophosphamide in operable breast cancer patients with positive axillary lymph nodes.","primaryOutcome":{"measure":"Number of Participants With Disease-Free Survival Events","timeFrame":"up to 10 year follow-up","effectByArm":[{"arm":"TAC (Docetaxel)","deltaMin":287,"sd":null},{"arm":"FAC (5-fluorouracil)","deltaMin":333,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0043"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":20,"countries":["United States","Argentina","Austria","Brazil","Canada","Czechia","Egypt","France","Germany","Greece","Hungary","Israel","Poland","Portugal","Slovakia","South Africa","Spain","Sweden","United Kingdom","Uruguay"]},"refs":{"pmids":["15930421","23246022"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":267,"n":744},"commonTop":["Any skin and subcutaneous tissue disorders","Alopecia","Any gastrointestinal disorders","Any general disorders and administration site conditions","Nausea"]}}